APA (7th ed.) Citation

CMP, J., MEL, F., FFA, V., VS, S., MAA, A., GC, M., . . . MVG, L. (2021). Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With Coronavirus Disease 2019 (COVID-19; Metcovid): A Randomized, Double-blind, Phase IIb, Placebo-controlled Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 72(9), e373. https://doi.org/10.1093/cid/ciaa1177

Chicago Style (17th ed.) Citation

CMP, Jeronimo, et al. "Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With Coronavirus Disease 2019 (COVID-19; Metcovid): A Randomized, Double-blind, Phase IIb, Placebo-controlled Trial." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 72, no. 9 (2021): e373. https://doi.org/10.1093/cid/ciaa1177.

MLA (9th ed.) Citation

CMP, Jeronimo, et al. "Methylprednisolone as Adjunctive Therapy for Patients Hospitalized With Coronavirus Disease 2019 (COVID-19; Metcovid): A Randomized, Double-blind, Phase IIb, Placebo-controlled Trial." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 72, no. 9, 2021, p. e373, https://doi.org/10.1093/cid/ciaa1177.